A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naïve inoperable non-small cell lung cancer in the elderly
- 31 August 2008
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 61 (2) , 214-219
- https://doi.org/10.1016/j.lungcan.2007.12.009
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Lung Cancer in the ElderlyJournal of Clinical Oncology, 2007
- Phase II Clinical Trial of Chemotherapy-Naïve Patients ≥ 70 Years of Age Treated With Erlotinib for Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2007
- Chemotherapy of advanced non-small cell lung cancer in elderly patientsAnnals of Oncology, 2006
- A Phase II Randomized Study of Paclitaxel Plus Carboplatin or Cisplatin against Chemo-Naive Inoperable Non-small Cell Lung Cancer in the ElderlyJournal of Thoracic Oncology, 2006
- Erlotinib in Previously Treated Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- Chemotherapy for Non-small Cell Lung Cancer in Elderly PatientsChest, 2005
- A randomised phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreatedBritish Journal of Cancer, 2004
- American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003Journal of Clinical Oncology, 2004
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1999